Trial intelligence / Profile preview

Fendrix vs Engerix-B in Healthy Adults

NCT00698555Phase 2Completed

Sponsor
GSK
Start
Mar 1997
Primary completion
May 1998
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Mar 1997; status: completed.

02

Drugs

hepatitis b vaccine recombinant
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT00698555.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00698555.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call